Non-Statin Therapy for LDL-Cholesterol Reduction in Primary and Secondary Prevention
September 11, 2018
In this program, experts James Underberg, MD, MS (Chair), Alan Brown, MD, Peter Jones, MD, and Pamela Morris, MD present compelling presentations and cases focusing on the evidence with, and use of, non-statin therapies for LDL-C lowering in the settings of primary and secondary prevention.
CME 0.00 Credits
LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy
June 17, 2018
n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.
CME 2.00 Credits
Understanding Childhood Narcolepsy: Why it’s more than just a Sleepy Child
January 02, 2018
CME 1.00 Credits
Demystifying Narcolepsy in Children: Pathways to Successful Outcomes
November 15, 2017
In this symposium, experts will address best practices in the diagnosis and treatment of narcolepsy, and explore hypersomnia mimics of narcolepsy in children.
CME 2.00 Credits
Management of Narcolepsy and excessive Daytime Sleepines in Obstructive Sleep Apnea
August 09, 2017
In this program, sleep experts including Richard Bogan, MD (Chair), and Suresh Kotagal, MBBS provide valuable insights and best practices for diagnosing and treating narcolepsy in children and adults. Case Studies and in depth participation by Atul Malhotra, MD, Patrick Strollo Jr., MD, and Lisa Collins, RRT, RPSGT, RCP
No Credit Available
LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS
April 08, 2017
In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.
No Credit Available
The Perfect Storm of Heart Failure and Diabetes: Insights into Pathophysiology and Evidence-Based Treatment Strategies
November 08, 2016
In this educational initiative, experts will address the needs of cardiologists for 1) a grasp of the relationship between DM and HF and the pathophysiology of HF in DM, 2) an explanation of clinical evidence for HF drugs in patients with DM, and 3) an assessment of the profiles of traditional and newer antidiabetic agents in patients with/at risk for cardiovascular disease and interpretation of heart failure-related outcomes.
No Credit Available
Best Practices for Managing Narcolepsy and Obstructive Sleep Apnea: Evidence-Based Strategies and Solutions
June 13, 2016
Thomas Scammell, MD (Chair), Richard Bogan, MD, Michael Thorpy, MD, and Phyllis Zee, MD, PhD address the challenges in the diagnosis of narcolepsy, identify best practices, and assess current and emerging strategies for treatment of EDS in OSA.
No Credit Available
Improving the Care of Patients with Narcolepsy: Evidence-Based Strategies
June 07, 2015
Michael J. Sateia, MD and Helene A Emsellem, MD and Shalanda L. Mitchell, RPSGT, RST describe best practices in recognition, diagnosis and treatment of narcolepsy.
No Credit Available
Optimizing Management of Recurrent Angina after PCI
May 08, 2015
Deepak Bhatt, MD, MPH, FSCAI (Chair); Duane Pinto, MD, FSCAI and Peter Stone, MD, MPH conduct a state-of-the-art discussion and case study on recurrent angina after PCI
No Credit Available
Demystifying Hypertriglyceridemia: Taking a Closer Look at Pathophysiology, Etiology, and Treatment
April 29, 2015
Eliot Brinton, MD and Terry Jacobson, MD discuss the pathophysiology, etiology, and treatment of hypertriglyceridemia.
No Credit Available
The Dynamics of In-Hospital and Post-Discharge ACS Management with Oral Antiplatelet Therapies
March 14, 2015
Jeffrey Anderson, MD, Van de Werf,MD and Marc Sabatine MD, discuss timing/location, dosing, duration of oral antiplatelet therapies, clinical trials, and guidelines.
No Credit Available